biote Corp.

Haymaker Acquisition Corp. II, listed under the ticker HYAC and sponsored by Haymaker Sponsor II, LLC, filed an amended quarterly report on Form 10-Q/A on November 29, 2021, under accession number 0001193125-21-342432. The blank-check company completed its initial public offering in 2021 and targeted the healthcare sector, ultimately announcing a business combination with biote Corp., a hormone optimization company that delivers pellet therapy through a physician-partner network. Amended quarterly filings of this type were common across the SPAC market in late 2021, often reflecting accounting adjustments related to SEC guidance issued earlier that year. Sign up for SpacDesk to access full filing histories, sponsor profiles, and deal analytics on HYAC and the broader SPAC universe.